相关实验视频

Updated: Jul 23, 2025

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production
06:18

Author Spotlight: Advancements in CAR-T Cell Manufacturing and Gene Therapy Production

Published on: August 18, 2023

2.7K

化学抗原受体T细胞的高成本:挑战和解决方案

Edward R Scheffer Cliff1,2, Amar H Kelkar2,3, David A Russler-Germain4

  • 1Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, MA.

American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
|July 11, 2023
PubMed
概括

化学抗原受体 (CAR) T细胞疗法对血液癌症有很大的前景,但面临着高成本. 需要新的策略来使这种先进的细胞免疫疗法在全球范围内负担得起和可访问.

更多相关视频

Production of Human CRISPR-Engineered CAR-T Cells06:33

Production of Human CRISPR-Engineered CAR-T Cells

Published on: March 15, 2021

13.1K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

664

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
567